In this study we analyzed peripheral blood samples from 40 patients with early-stage breast cancer treated with DOX-based chemotherapy for protein and mRNA expression of PGLYRP1, CAMP, MMP9 and CEACAM8. The gene discussed is PGLYRP1; the disease is breast carcinoma.